ORA Obtaining ACRA Signature SOP

The FDA has notified NTEU that it plans to implement a SOP entitled “Obtaining ACRA Signature.”

Associate Commissioner for Regulatory Affairs Melinda Plaisier
Associate Commissioner for Regulatory Affairs Melinda Plaisier

Pursuant to Article 3 of the Consolidated Collective Bargaining Agreement, the FDA has notified NTEU that the ORA Office of Partnerships (OP) plans to implement a Standard Operating Procedure (SOP) entitled “Obtaining ACRA Signature.” Per the notice, ‎the purpose of the SOP is to establish supplemental procedures for the submission of letters and other documents for signature by the Associate Commissioner for Regulatory Affairs.

NTEU plans to negotiate over the matter and has requested a briefing for that purpose.

If you have any comments or questions, please contact your chapter president.